Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond62
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo45
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer26
Immune Cell Metabolism and Immuno-Oncology24
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy23
Allogeneic CAR T Cell Therapy for Cancer22
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?20
Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer19
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division19
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies18
Road Map to Defeat Pancreatic Cancer16
Cancer Dependency Map: Past and Present16
An Erratic Path Toward Discovery13
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches13
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy13
0.031423807144165